Bacopa monnieri or brahmi, is an ayruvedic herb with a long history of use for supporting the brain. Recent clinical trials appear to support its historical uses.
Intranasal ketamine has been approved for the treatment of depression. Current levels of evidence still raise concerns about its safety and efficacy.
Recent research has started to suggest that air pollution may be a significant risk factor in the development of dementia.
Light therapy appears to be an effective treatment option for reducing the symptoms of nasal allergies.
Sleep deprivation often has a surprising short-term benefit on the symptoms of depression. Certain techniques might be able to extend the effects to help relieve depressive symptoms.